The study demonstrated that fibronectin secreted by CAFs activates the PI3K/Akt signaling pathway to inhibit tumor cell apoptosis and, in cooperation with collagen, induces matrix metalloproteinase (MMP) expression, contributing to increased resistance to gemcitabine treatment [46,47,48]. This evidence concerns the gene FN1 and neoplasm.